2Schartl M, Bocksch W, Koschyk DH, et al. Use of intravascular ultrasound to compare effects of different strategies of lipidlowering therapy on plaque volume and composition in patients with coronary artery disease[J]. Circulation, 2001, 104(4): 387 - 392.
3Crisby M, Nordin-Fredriksson G, Shah PK, et al. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques : implications for plaque stabilization [ J ]. Circulation,2001,103(7) : 926 - 933.
4Takano M, Mizuno K, Yokoyama S, et al. Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin: serial evaluation by coronary angioscopy[J]. J Am Coil Cardiol, 2003, 42(4): 680- 686.
5Stenestrand U, Wallentin L. Early statin treatment following acute myocardial infarction and 1-year survival [ J]. JAMA, 2001,285:430 - 436.
6Spencer FA, Allegrone J, Goldberg RJ, et al. Association of statin therapy with outcomes of acute coronary syndrome: the GRACE study[J]. Ann Intern Med, 2004,140:857- 866.
7Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastain on early recurrent ischemic events in acute ccoronary syndromes- the MIRACLE study. Arandomized controlled trial[J]. JAMA, 2001,285:1711- 1718.
8Cannon CP, I Braunwald E, McCabe C, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes[J]. N Engl J Med, 2004,350:1495- 1504.
9Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part Ⅰ[J]. Circulation, 2003, 108(14): 1664 - 1672.
10Topoi EJ. Intensive statin therapy-A sea change in cardiovascular prevention[J]. N Engl J Med, 2004,350:1562- 1564.
